These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 20676736
41. Intestinal solubility and absorption of poorly water soluble compounds: predictions, challenges and solutions. Fagerberg JH, Bergström CA. Ther Deliv; 2015; 6(8):935-59. PubMed ID: 26316058 [Abstract] [Full Text] [Related]
42. Biorelevant media simulating fed state intestinal fluids: colloid phase characterization and impact on solubilization capacity. Kleberg K, Jacobsen F, Fatouros DG, Müllertz A. J Pharm Sci; 2010 Aug; 99(8):3522-32. PubMed ID: 20564382 [Abstract] [Full Text] [Related]
47. Gastrointestinal diseases and their impact on drug solubility: Ulcerative Colitis. Effinger A, M O'Driscoll C, McAllister M, Fotaki N. Eur J Pharm Sci; 2020 Sep 01; 152():105458. PubMed ID: 32645424 [Abstract] [Full Text] [Related]
48. Dissolution behavior of various drugs in different FaSSIF versions. Klumpp L, Leigh M, Dressman J. Eur J Pharm Sci; 2020 Jan 15; 142():105138. PubMed ID: 31704344 [Abstract] [Full Text] [Related]
49. Improved Prediction of in Vivo Supersaturation and Precipitation of Poorly Soluble Weakly Basic Drugs Using a Biorelevant Bicarbonate Buffer in a Gastrointestinal Transfer Model. Jede C, Wagner C, Kubas H, Weigandt M, Weber C, Lecomte M, Badolo L, Koziolek M, Weitschies W. Mol Pharm; 2019 Sep 03; 16(9):3938-3947. PubMed ID: 31335153 [Abstract] [Full Text] [Related]
50. Developing a predictive in vitro dissolution model based on gastrointestinal fluid characterisation in rats. Christfort JF, Strindberg S, Plum J, Hall-Andersen J, Janfelt C, Nielsen LH, Müllertz A. Eur J Pharm Biopharm; 2019 Sep 03; 142():307-314. PubMed ID: 31288077 [Abstract] [Full Text] [Related]
51. Characterization of the ascending colon fluids in ulcerative colitis. Vertzoni M, Goumas K, Söderlind E, Abrahamsson B, Dressman JB, Poulou A, Reppas C. Pharm Res; 2010 Aug 03; 27(8):1620-6. PubMed ID: 20428929 [Abstract] [Full Text] [Related]
55. Model-Based Analysis of Biopharmaceutic Experiments To Improve Mechanistic Oral Absorption Modeling: An Integrated in Vitro in Vivo Extrapolation Perspective Using Ketoconazole as a Model Drug. Pathak SM, Ruff A, Kostewicz ES, Patel N, Turner DB, Jamei M. Mol Pharm; 2017 Dec 04; 14(12):4305-4320. PubMed ID: 28771009 [Abstract] [Full Text] [Related]
56. Small scale in vitro method to determine a bioequivalent equilibrium solubility range for fasted human intestinal fluid. Abuhassan Q, Khadra I, Pyper K, Halbert GW. Eur J Pharm Biopharm; 2021 Nov 04; 168():90-96. PubMed ID: 34419602 [Abstract] [Full Text] [Related]
57. Ethanol effects on apparent solubility of poorly soluble drugs in simulated intestinal fluid. Fagerberg JH, Al-Tikriti Y, Ragnarsson G, Bergström CA. Mol Pharm; 2012 Jul 02; 9(7):1942-52. PubMed ID: 22651218 [Abstract] [Full Text] [Related]
58. Characterization of neonatal and infant enterostomy fluids - part II: Drug solubility. de Waal T, Brouwers J, Rayyan M, Stillhart C, Vinarova L, Vinarov Z, Augustijns P. Int J Pharm; 2023 Jul 25; 642():123141. PubMed ID: 37321462 [Abstract] [Full Text] [Related]